Publication | Closed Access

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

TransplantationMarrow TransplantationElderly PatientsPost-transplant Cyclophosphamide DosesBone Marrow FailureStem Cell TransplantationHematologyHematological MalignanciesRadiation OncologyMedicineCell TransplantationHealth Sciences